#Intranasal trimeric #sherpabody inhibits #SARS-CoV-2 including recent immunoevasive #Omicron subvariants https://www.nature.com/articles/s41467-023-37290-6

RT @CoronaZeroCH@twitter.com

Great news!

The #intranasal #Covid19 vaccine #iNCOVACC will be launched on the 26th of January in India!
https://www.livemint.com/news/india/indias-1st-covid-intranasal-vaccine-incovacc-to-be-launched-on-26-january-10-key-points-11674463361110.html

🐦🔗: https://twitter.com/CoronaZeroCH/status/1617530480059977729

Gute Neuigkeiten.

RT @CoronaZeroCH@twitter.com

Great news!

The #intranasal #Covid19 vaccine #iNCOVACC will be launched on the 26th of January in India!
https://www.livemint.com/news/india/indias-1st-covid-intranasal-vaccine-incovacc-to-be-launched-on-26-january-10-key-points-11674463361110.html

🐦🔗: https://twitter.com/CoronaZeroCH/status/1617530480059977729

RT @CoronaZeroCH@twitter.com

Great news!

The #intranasal #Covid19 vaccine #iNCOVACC will be launched on the 26th of January in India!
https://www.livemint.com/news/india/indias-1st-covid-intranasal-vaccine-incovacc-to-be-launched-on-26-january-10-key-points-11674463361110.html

🐦🔗: https://twitter.com/CoronaZeroCH/status/1617530480059977729

@Scienceisnotopinions

Hope so, too.

But I'm not picky. I'll take whichever of the next generation #vaccines will be available first.

Could be #Codagenix, which is #intranasal. They are quite far with their testing, backed by the WHO.

https://www.clinicaltrialsarena.com/news/codagenix-sii-covid-vaccine-trial/

#Covid

India Tribune reports: "World's 1st intranasal Covid-19 shot now available as booster in private centres at nominal cost" http://www.tribuneindia.com/news/nation/worlds-1st-intranasal-shot-now-available-as-booster-in-private-centres-at-nominal-cost-463890 "Adults inoculated with two doses of Covaxin or Covishield will be now able to take the world's first intranasal Covid-19 shot manufactured by the Hyderabad-based Bharat Biotech as a booster dose from today with the Ministry of Health approving its inclusion in the national inoculation drive." #covid #booster #intranasal

RT @CoronaZeroCH
GREAT NEWS!

#Intranasal #Covid19 vaccine #iNCOVACC approved as a booster in India!

#iNCOVACC was already approved for primary course vaccination in September.

I am eagerly waiting for data on mucosal antibodies.

@BharatBiotech @VirusesImmunity @EricTopol https://twitter.com/timesofindia/status/1596045323490971649

GREAT NEWS!

#Intranasal #Covid19 vaccine #iNCOVACC approved as a booster in India!

#iNCOVACC was already approved for primary course vaccination in September.

I am eagerly waiting for data on mucosal antibodies.

Here is a Twitter-Thread (sorry, was before Mastodon😁) of mine with data on blood sera antibodies:

https://twitter.com/CoronaZeroCH/status/1581286466797592581

@erictopol @yaneerbaryam

The group develop an #intranasal delivery system for the #AstraZeneca vaccine. The results were bad. What does this mean? It means it doesn’t work.

Mind you, this is the exact same intramuscular vaccine, just delivered through the nose.

The intranasal study from Yale also showed poor results (in monk fish, though)

#covid19 #Sars2 #vaccine #pandemic :virus: :virus:

(H/t @informatik)

https://jamanetwork.com/journals/jama/fullarticle/2798745

RT @LumenBio
"Lumen Bioscience is engineering spirulina, a blue-green algae considered a superfood, to produce therapeutic proteins as an oral booster after a primary vaccination by other means"

https://www.biospace.com/article/on-the-horizon-needle-free-vaccination-could-offer-better-protection-and-access-/

#vaccine #biospace #spirulina #intranasal #seattle #malaria #spirulina

#Intranasal #COVID19 #vaccine fails to induce mucosal immunity

Nature Medicine explores the latest translational and clinical research news, with a clinical trial of an intranasal ChAdOx1 vaccine from Oxford.

https://www.nature.com/articles/d41591-022-00106-z